Modified Bortezomib-based Combination Therapy for Multiple Myeloma
Clinical trial NCT02559154 · UNKNOWN
Trial details
- NCT number
- NCT02559154
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2018-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.